Fostriecin sodium salt

CAS: 87860-39-7

Ref. 3D-MDA86039

Produktinformation

• Name: Fostriecin sodium salt
• Synonyme: (2Z,5R,6E,8R,9R,11R,12Z,14Z,16E)-8,11,18-Trihydroxy-9-(phosphonooxy)-octadeca-2,6,12,14,16-pentaeno-5-lactone monosodium salt, 2H-Pyran-2-one, 5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-, sodium salt (1:1), (6R)-, 2H-Pyran-2-one, 5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodium salt, (6R)-, Cl-1565A, Fostriecin sodium, Pd-110161, sodium (1R,3R,4Z,6Z,8E)-3,10-dihydroxy-1-{(1R,2E)-1-hydroxy-1-methyl-3-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]prop-2-en-1-yl}deca-4,6,8-trien-1-yl hydrogen phosphate

Beschreibung

Fostriecin sodium salt is an immunosuppressant that is used to prevent organ rejection in patients who have received a transplanted organ. It binds to antibodies and prevents their binding to antigens on the transplanted organ, thus preventing antibody response. Fostriecin sodium salt has been shown to be effective in reducing the incidence of autoimmune disease, cancer, and graft-versus-host disease. The effective dose for this drug is 5mg/kg/day. Fostriecin sodium salt may be administered orally or intravenously. This immunosuppressant does not alter the regulatory immune system or suppress the body's natural immunity.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 452.37 g/mol
• Formel: C₁₉H₂₆O₉PNa
• Reinheit: Min. 95%